evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract
17746,GENE_BACKGROUND,,"CEBPA encodes a basic region leucine zipper (bZIP) transcription factor that can homo- or heterodimerizes to bind DNA and activates transcription (PMID: 25753223). Through interactions by its transactivation domain, it can help recruit the RNA polymerase complex, coactivators CBP (Creb binding protein) /p300, and chromatin modifying complexes SWI/SNF (switch/sucrose nonfermentable) (PMID: 12857754, 14660596). CEBPA gene regulation is important for the differentiation of diverse cell types including hematopoietic, adiopose, liver and epithelial cells (PMID: 7652557, 23160954, 12757710). In lung cancer, CEBPA may suppress tumorigenesis (PMID: 17638888). In hematopoiesis, CEBPA is important for the development of the myeloid lineage and granulocytic differentiation by regulating specific growth factor receptors and cell cycle arrest (PMID: 25753223). CEBPA mutations are found in acute myeloid leukemia (AML) and in inherited AML predisposition syndromes (PMID: 11242107, 12351377, 25311743, 23560626).",,2017-03-22,,1050,CEBPA,CCAAT/enhancer binding protein alpha,False,ENST00000498907,NM_004364.3,C/EBP-alpha,CEBP,True,12351377,Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA).,Blood,2018-10-15T20:02:00,100,8,2717-23,Preudhomme C et al,,,0001-10-15,,12757710,Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest.,Cell,2018-05-16T20:03:00,113,4,495-506,Iakova P et al,,,2018-05-16T05:06:00,,25753223,C/EBPα in normal and malignant myelopoiesis.,International journal of hematology,2018-04-01T20:15:00,101,4,330-41,Friedman AD,doi: 10.1007/s12185-015-1764-6,,0001-04-01,,23160954,C/EBP transcription factors mediate epicardial activation during heart development and injury.,"Science (New York, N.Y.)",2017-12-21T20:12:00,338,6114,1599-603,Huang GN et al,doi: 10.1126/science.1229765,,2017-12-21T06:03:00,,12857754,CCAAT/enhancer-binding protein family members recruit the coactivator CREB-binding protein and trigger its phosphorylation.,The Journal of biological chemistry,2018-09-19T20:03:00,278,38,36959-65,Kovács KA et al,,,0001-09-19,,17638888,Genetic ablation of CCAAT/enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis.,Cancer research,2018-07-15T20:07:00,67,14,6768-76,Loomis KD et al,,,0001-07-15,,14660596,The CCAAT enhancer-binding protein alpha (C/EBPalpha) requires a SWI/SNF complex for proliferation arrest.,The Journal of biological chemistry,2018-02-20T20:04:00,279,8,7353-8,Müller C et al,,,0001-02-20,,23560626,GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations.,British journal of haematology,2018-06-01T20:13:00,161,5,701-5,Green CL et al,doi: 10.1111/bjh.12317,,0001-06-01,,11242107,"Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.",Nature genetics,2018-03-01T20:01:00,27,3,263-70,Pabst T et al,,,0001-03-01,,7652557,Impaired energy homeostasis in C/EBP alpha knockout mice.,"Science (New York, N.Y.)",0001-08-25,269,5227,1108-12,Wang ND et al,,,0001-08-25,,25311743,Inherited predisposition to acute myeloid leukemia.,Seminars in hematology,2018-10-01T20:14:00,51,4,306-21,Godley LA,doi: 10.1053/j.seminhematol.2014.08.001,,0001-10-01,
17745,GENE_SUMMARY,,CEBPA encodes a transcription factor involved in proliferation arrest and differentiation. Mutations of CEBPA are found in leukemias.,,2017-03-22,,1050,CEBPA,CCAAT/enhancer binding protein alpha,False,ENST00000498907,NM_004364.3,C/EBP-alpha,CEBP,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
